Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024)
Xeris Biopharma Holdings (XERS) reported Tax Provisions of -$3.3 million for Q3 2024, down 883.43% on a YoY basis from $424287.0 in Q4 2023, and down 543.79% quarter-over-quarter from $749000.0 in Q2 2024.
Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024) Analysis & Trends
Xeris Biopharma Holdings has reported Tax Provisions for 3 years, with the latest figure at -$3.3 million in Q3 2024.
- For the quarter ending Q3 2024, Tax Provisions fell 883.43% year-over-year to -$3.3 million; the trailing twelve-month figure through Jun 2025 stood at -$3.3 million (down 789.63% YoY), and the FY2024 full-year result was -$2.3 million, down 81.59% from the prior year.
- Tax Provisions for Q3 2024 stood at -$3.3 million, down from $749000.0 in the prior quarter.
- The five-year high for Tax Provisions was $749000.0 in Q2 2024, with the low at -$3.3 million in Q3 2024.
- Historically, Tax Provisions has averaged -$494100.0 across 3 years, with a median of -$338500.0 in 2022.
- The largest YoY upside for Tax Provisions was 210.96% in 2024 against a maximum downside of 883.43% in 2024.
- Xeris Biopharma Holdings' Tax Provisions stood at -$338000.0 in 2022, then surged by 30.18% to -$236000.0 in 2023, then plunged by 1308.47% to -$3.3 million in 2024.
- The last three Tax Provisions figures came in at -$3.3 million (Q3 2024), $749000.0 (Q2 2024), and $307000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 37.99 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.44 Mn |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | -236,000.00 |
| Sep 30, 2023 | -338,000.00 |
| Jun 30, 2023 | -675,000.00 |
| Dec 31, 2022 | -338,000.00 |
| Sep 30, 2022 | -339,000.00 |
| Jun 30, 2022 | -339,000.00 |
| Mar 31, 2022 | -408,000.00 |